Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes? | Aplastic Anemia and MDS International Foundation

Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

Journal Title: 
Haematologica
Primary Author: 
Kosmider O
Author(s): 
Kosmider O, Passet M, Santini V, Platzbecker U, Andrieu V, Zini G, Beyne-Rauzy O, Guerci A, Masala E, Balleari E, Bulycheva E, Dreyfus F, Fenaux P, Fontenay M, Park S
Original Publication Date: 
Thursday, April 7, 2016

No abstract available.

Bone Marrow Diseases: